コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dules, rheumatoid factor seropositivity, and erythrocyte sedimentation rate).
2 se reactants, such as C-reactive protein and erythrocyte sedimentation rate.
3 joints with limited range of motion; and 6) erythrocyte sedimentation rate.
4 odified Health Assessment Questionnaire, and erythrocyte sedimentation rate.
5 arrhea, fever, weight loss, and an increased erythrocyte sedimentation rate.
6 normal C-reactive protein level, and normal erythrocyte sedimentation rate.
7 perlipidemia is indicated by their increased erythrocyte sedimentation rate.
8 e protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.
9 th the presence of nephritis and an elevated erythrocyte sedimentation rate.
10 elated, in part, to smoking and an increased erythrocyte sedimentation rate.
11 ed by disease duration, 5% by the Westergren erythrocyte sedimentation rate, 14% by articular signs a
12 27% traditional bulk (> 10 cm), 52% elevated erythrocyte sedimentation rate, 21% extranodal involveme
13 nt 29.4, mean swollen joint count 17.4, mean erythrocyte sedimentation rate 25.1 mm/hour) despite tre
14 ures [3 patient and 3 assessor measures plus erythrocyte sedimentation rate]); 3) patient-only (media
15 ints, Larsen radiographic score 20 versus 3, erythrocyte sedimentation rate 33 mm/hour versus 20, and
16 6 months (mean tender joint count 28.2, mean erythrocyte sedimentation rate 46.5 mm/hour) were random
17 L; reference range, 0.0-0.5 mg/dL), elevated erythrocyte sedimentation rate (60 mm/h; reference range
18 L; reference range, 0.0-0.5 mg/dL), elevated erythrocyte sedimentation rate (60 mm/h; reference range
20 ne kinase, thyroid-stimulating hormones, and erythrocyte sedimentation rate; all analyses were perfor
21 natriuretic peptide, C-reactive protein, and erythrocyte sedimentation rate), an electrocardiogram, t
22 respectively, of 0.54-0.78 and 0.46-0.95 for erythrocyte sedimentation rate and 0.73 and 0.78 for C-r
28 mality of common inflammatory markers (i.e., erythrocyte sedimentation rate and C-reactive protein) w
30 ned the relation between leukocyte count and erythrocyte sedimentation rate and diabetes incidence us
31 related with biomarkers of disease activity (erythrocyte sedimentation rate and double-stranded DNA c
32 serum albumin; MR was associated with higher erythrocyte sedimentation rate and lower albumin at all
34 cular dysfunction was associated with higher erythrocyte sedimentation rate and, at diagnosis only, l
36 articipants, the use of drugs was noted, and erythrocyte sedimentation rates and serum levels of high
37 ESR (disease activity score in 28 joints for erythrocyte sedimentation rate) and complement system ge
38 nia, thrombocytosis, C-reactive protein, and erythrocyte sedimentation rate); and (3) vasculopathy si
39 acute-phase reactants (C-reactive protein), erythrocyte sedimentation rate, and bone metabolism mark
40 ng hormone level, autoimmune antibody level, erythrocyte sedimentation rate, and C-reactive protein l
41 d culture, electrolyte panel, liver enzymes, erythrocyte sedimentation rate, and C-reactive protein l
42 me) and disease activity (total joint count, erythrocyte sedimentation rate, and C-reactive protein)
43 uality of life, enthesitis, chest expansion, erythrocyte sedimentation rate, and C-reactive protein,
45 , exhibited higher C-reactive protein (CRP), erythrocyte sedimentation rate, and comorbidities such a
46 plained, statistically, by pain, depression, erythrocyte sedimentation rate, and disease duration.
48 ood glucose, urinary albumin creatine ratio, erythrocyte sedimentation rate, and high-sensitivity C-r
49 mation markers C-reactive protein (CRP), the erythrocyte sedimentation rate, and interleukin-6 (IL-6)
51 ated with a reduction in C-reactive protein, erythrocyte sedimentation rate, and pericardial LGE in t
52 ectively), and lower white blood cell count, erythrocyte sedimentation rate, and platelet count (all
53 l sites, lactate dehydrogenase (LDH) levels, erythrocyte sedimentation rate, and platelet count did n
55 gher anti-double-stranded DNA (dsDNA) titer, erythrocyte sedimentation rate, and SLE Disease Activity
56 seline and week 4 in the tender joint count, erythrocyte sedimentation rate, and urinary excretion of
57 d significantly increased neutrophil counts, erythrocyte sedimentation rates, and C-reactive protein,
58 mplete blood cell counts, metabolic factors, erythrocyte sedimentation rates, and levels of C-reactiv
60 demonstrated that a model which included the erythrocyte sedimentation rate at baseline (P = 0.005) a
61 k factors (ie, age, clinical stage, elevated erythrocyte sedimentation rate, B symptoms, large medias
62 ients who entered the trial with an elevated erythrocyte sedimentation rate but normal CRP level.
63 ), joint swelling, joint pain or tenderness, erythrocyte sedimentation rate, C-reactive protein level
65 markers of inflammation (such as leukocytes, erythrocyte sedimentation rate, C-reactive protein, and
67 African American patients with PN had higher erythrocyte sedimentation rate, C-reactive protein, ferr
68 e with blood tests (Xpert MTB host-response, erythrocyte sedimentation rate, C-reactive protein, Quan
69 f the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-reactive protein, tube
71 eumatologist ranked ACR 20, radiography, and erythrocyte sedimentation rate/c-reactive protein as the
74 eline levels of C-reactive protein and lower erythrocyte sedimentation rates compared with patients d
76 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
77 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
78 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
79 isease Activity Score in 28 joints using the erythrocyte sedimentation rate (DAS28-ESR) was >/=3.2.
81 tionship with disease activity score 28 with erythrocytes sedimentation rate (DAS28[ESR]) and Sharp s
82 ctivity (disease activity score in 28 joints-erythrocyte sedimentation rate [DAS28-ESR] >/= 3.2 [rang
83 [LDA] according to Disease Activity Score 28-erythrocyte sedimentation rate [DAS28-ESR] </=3.2 or DAS
87 f 5.29 mg to 0.34 mg per deciliter), and the erythrocyte sedimentation rate decreased at month 3 (all
89 osteomyelitis may have an increase in their erythrocyte sedimentation rate during the first 2 weeks
90 (anemia, thrombocytopenia leukocytosis, high erythrocyte sedimentation rate, elevated levels of C-rea
91 ips, or proximal aspects of the thighs), and erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
92 ck, shoulders, or hip girdle regions; and an erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
93 e age <65 years (OR = 10.647, P = 0.023) and erythrocyte sedimentation rate (ESR) >30 (OR = 6.414, P
94 (adjusted OR, 2.71 [95% CI, 1.26-5.86]), and erythrocyte sedimentation rate (ESR) >40 mm/h (adjusted
95 variate analysis, age younger than 60 years, erythrocyte sedimentation rate (ESR) 20 mm/h or less, an
98 There is a positive correlation between the erythrocyte sedimentation rate (ESR) and large bowel upt
99 ents were assessed for correlations with the erythrocyte sedimentation rate (ESR) and platelet count.
100 riate analysis for EFS are stage of disease, erythrocyte sedimentation rate (ESR) at diagnosis, liver
101 of the respondents reported using either the erythrocyte sedimentation rate (ESR) or C-reactive prote
102 ), RA disease activity score 28 (DAS28), and erythrocyte sedimentation rate (ESR) were measured at ba
103 th, the Health Assessment Questionnaire, and erythrocyte sedimentation rate (ESR) were used to develo
105 nderness, 3) physician global assessment, 4) erythrocyte sedimentation rate (ESR), 5) functional disa
108 s were calculated to estimate effect of age, erythrocyte sedimentation rate (ESR), and C-reactive pro
109 effect of acupuncture on morning stiffness, erythrocyte sedimentation rate (ESR), and C-reactive pro
110 and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and platelets for
111 a, hematuria, low hemoglobin level, elevated erythrocyte sedimentation rate (ESR), and presence of an
113 ere obtained periodically for measurement of erythrocyte sedimentation rate (ESR), C-reactive protein
114 and analyzed for complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein
115 nd rheumatoid factor-negative polyarthritis, erythrocyte sedimentation rate (ESR), C-reactive protein
116 fasting insulin, glucose, and lipid levels, erythrocyte sedimentation rate (ESR), C-reactive protein
117 at every visit included determination of the erythrocyte sedimentation rate (ESR), grip strength, pai
118 ic markers such as C-reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR), haemoglobin-A1C (H
119 lesterol, triglycerides, C-reactive protein, erythrocyte sedimentation rate (ESR), hemoglobin, total
122 rythrocyte aggregation were also determined: erythrocyte sedimentation rate (ESR), zeta sedimentation
128 host-related [age; hematological parameters; erythrocyte sedimentation rate (ESR); C-reactive protein
129 tor (RF) positivity (93% versus 84%), higher erythrocyte sedimentation rate (ESR; 45 versus 36 mm/hr)
130 correlated with untreated disease activity (erythrocyte sedimentation rate [ESR]) (r = 0.5, P = 0.00
131 ammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (t
132 hysician's and patient's global assessments, erythrocyte sedimentation rate [ESR], and morning stiffn
133 atory markers (white blood cell [WBC] count, erythrocyte sedimentation rate [ESR], C-reactive protein
134 enderness, swelling, and deformity, nodules, erythrocyte sedimentation rate [ESR], C-reactive protein
135 onnaire), and serum markers of inflammation (erythrocyte sedimentation rate [ESR], high-sensitivity C
136 rity (rheumatoid factor [RF] seropositivity, erythrocyte sedimentation rate [ESR], joint swelling, ra
137 tional diagnostic tests include blood tests (erythrocyte sedimentation rate, ESR; C-reactive protein,
139 ious infection, corticosteroid use, elevated erythrocyte sedimentation rate, extraarticular manifesta
140 ps with regard to abnormal elevations of the erythrocyte sedimentation rate following initial remissi
141 of amyloid A and C-reactive protein, and the erythrocyte sedimentation rate from baseline to month 3
143 ture >38.8 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
144 ture >38.3 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
145 ions (P = 0.01), myositis (P = 0.02), and an erythrocyte sedimentation rate >40 mm/hour (P < 0.001) w
146 (49.7 mg/L; reference range, 0.0-8.0 mg/L), erythrocyte sedimentation rate (>140 mm/h with Westergre
148 naire Disability Scale, global severity, and erythrocyte sedimentation rate had a 3-6 times increased
150 joint counts, C-reactive protein levels, and erythrocyte sedimentation rates had fallen significantly
152 ch as HLA-B27 status, C-reactive protein and erythrocyte sedimentation rate have, at best, moderate d
153 on, and basic blood tests, which include the erythrocyte sedimentation rate, hemoglobin, white count,
154 greater physical function limitation, higher erythrocyte sedimentation rate, higher joint count sever
155 CI) 0.03-0.35, P < 0.0005]), as was a higher erythrocyte sedimentation rate (HR 0.80 [95% CI 0.67-0.9
156 ngoing inflammation as indicated by elevated erythrocyte sedimentation rate, hypocomplementemia, and/
159 those for the C-reactive protein levels and erythrocyte sedimentation rates in the same patients.
160 evated peripheral white blood cell count and erythrocyte sedimentation rate may herald an infection o
161 of tocilizumab, the C-reactive protein level/erythrocyte sedimentation rate normalized, while placebo
162 erythrocytes may contribute to the elevated erythrocyte sedimentation rates observed in inflammatory
163 usted hazard ratios for participants with an erythrocyte sedimentation rate of > or = 26 mm/hour comp
164 6 mm/hour compared with participants with an erythrocyte sedimentation rate of < or = 5 mm/hour were
165 f 8.5 IU/mL (normal range, 0-13.9 IU/mL), an erythrocyte sedimentation rate of 2 mm/hr (normal range,
166 % eosinophils [normal range, 1%-4%]), and an erythrocyte sedimentation rate of 31 mm per hour (normal
167 ormal value, <10 mg/L [95.2 nmol/L]), and an erythrocyte sedimentation rate of 35 mm per hour (normal
168 l of 47 g/L (normal range, 26-32 g/L) and an erythrocyte sedimentation rate of 36 mm/h (normal range,
169 el of less than 5 mg/L (47.6 nmol/L), and an erythrocyte sedimentation rate of 41 mm/h (0-15 mm/h).
170 % eosinophils [normal range, 1%-4%]), and an erythrocyte sedimentation rate of 5 mm per hour (normal
172 cts were noted in individual ACR components, erythrocyte sedimentation rate, onset of ACR20 response,
173 th the inflammatory variant have an elevated erythrocyte sedimentation rate or abnormalities of other
174 , even without immediate availability of the erythrocyte sedimentation rate or the C-reactive protein
175 smoking (OR 1.02, P = 0.04) and an elevated erythrocyte sedimentation rate (OR 1.02, P = 0.05) were
176 phocytosis (OR, 1.84; P = 0.0002), increased erythrocyte sedimentation rate (OR, 6.5; P = 0.0005), de
177 .039), low serum C4 (P = 0.046), an elevated erythrocyte sedimentation rate (P = 0.006), and abnormal
178 -glycoprotein concentration (p = 0.012), and erythrocyte sedimentation rate (p = 0.01); concentration
179 creases in albumin (P<.001) and decreases in erythrocyte sedimentation rate (P<.05), interleukin-6 (P
180 ated patients had greater mean reductions in erythrocyte sedimentation rate (p=0.009) and a two-fold
181 italization (P=0.05) and, at week 1, a lower erythrocyte sedimentation rate (P=0.02) and a tendency t
182 nts who experienced complications had higher erythrocyte sedimentation rates (P<0.001) and C-reactive
183 ficant improvement in 3 of 5 core variables (erythrocyte sedimentation rate, physician's global asses
184 4) levels were significantly reduced, as was erythrocyte sedimentation rate, possibly as a result of
185 orrelated with the C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor level,
186 disease duration, C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, nodul
187 o had higher baseline C-reactive protein and erythrocyte sedimentation rate than the persistent CP gr
188 interval 1.18-12.59], P=0.026) alongside the erythrocyte sedimentation rate, triglyceride level, pred
190 he most frequent presenting symptom, and the erythrocyte sedimentation rate was elevated in 98% of ca
192 lower physical QOL during followup, whereas erythrocyte sedimentation rate was most strongly associa
193 7.023), and 2.9-fold higher when an elevated erythrocyte sedimentation rate was present (p = 0.077, O
194 and C-reactive protein (CRP), as well as the erythrocyte sedimentation rate were measured serially.